Nrf2 activators, including CDDO-Im, sulforaphane, and dimethyl fumarate (DMF), were shown to inhibit vaso occlusion and vascular inflammation in models of SCD [34,35,36]. Here, NFE2L2 is linked to Schnyder corneal dystrophy.